Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7595304

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
15,269,000,000 JPY
56,607,000,000 JPY
14,221,000,000 JPY
Ordinary profit (loss)
1,805,000,000 JPY
4,880,000,000 JPY
1,329,000,000 JPY
Net assets
50,477,000,000 JPY
48,892,000,000 JPY
45,313,000,000 JPY
Total assets
84,764,000,000 JPY
83,297,000,000 JPY
81,717,000,000 JPY
Basic earnings (loss) per share
46.94
151.22
38.72
Diluted earnings per share
Equity-to-asset ratio
0.596 xbrli:pure
0.587 xbrli:pure
0.555 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.